Drug shortage
Plerixafor Injection · Fresenius Kabi USA, LLC
FDA drug shortage · To Be Discontinued · updated Mar 13, 2026
Key facts
| Generic name | Plerixafor Injection |
|---|---|
| Company | Fresenius Kabi USA, LLC |
| Presentation | Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Hematology |
| Package NDCs | 65219-284-12 |
| First posted | Mar 13, 2026 |
| Last updated | Mar 13, 2026 |
| Discontinued | Mar 13, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: